Research published in PLoS Medicine this week by Weijia Xing and colleagues examines the publication of epidemiological literature concerning the 2003 severe acute respiratory syndrome (SARS) outbreaks in Hong Kong and Toronto. The research shows that the majority of the epidemiological articles on SARS were submitted after the epidemic had ended (22% submitted during the epidemic) with only 7% being published during the epidemic. These findings show that although the academic response to the SARS epidemic was rapid, most articles on the epidemiology of SARS were published after the epidemic was over.
Outbreaks of emerging infectious diseases, especially those of a global nature, require rapid epidemiological analysis and dissemination of information for which journals are just one channel. This paper suggests that journals alone are not sufficient. The authors conclude by suggesting that to minimize future delays in the publication of epidemiological research on emerging infectious diseases, epidemiologists could adopt common, predefined protocols and ready-to-use instruments, which would improve timeliness and ensure comparability across studies. Journals, in turn, could improve their fast-track procedures.
Funding: This work was funded by the Sixth Framework Programme for Research for Policy Support (contract SP22-CT-2004-511066) from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
Citation: Xing W, Hejblum G, Leung GM, Valleron A-J (2010) Anatomy of the Epidemiological Literature on the 2003 SARS Outbreaks in Hong Kong and Toronto: A Time-Stratified Review. PLoS Med 7(5): e1000272. doi:10.1371/journal.pmed.1000272
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000272
PRESS-ONLY PREVIEW OF THE ARTICLE: www.plos.org/press/plme-07-05-xing.pdf
CONTACT:
Weijia Xing
INSERM & UPMC Univ Paris 6
UMR S 707
Faculté de Médecine Saint-Antoine
27 RUE CHALIGNY
Paris, ILE DE FRANCE F-75012
France
0033-149283227
0033-149283233 (fax)
weijia.xing@inserm.fr
PLOS Medicine